# Novel Treatment for Syndromic Ichthyoses

> **NCT01110642** · PHASE2 · WITHDRAWN · sponsor: **Northwestern University**

## Conditions studied

- Syndromic Ichthyoses
- CHILD Syndrome
- Smith Lemli Opitz Syndrome
- Conradi Syndrome

## Interventions

- **DRUG:** Lovastatin

## Key facts

- **NCT ID:** NCT01110642
- **Lead sponsor:** Northwestern University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2011-07
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study was withdrawn due to lack of eligible population for study
- **Last updated:** 2015-05-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01110642

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01110642, "Novel Treatment for Syndromic Ichthyoses". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01110642. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*